Nalbuphine and slow release morphine.
作者信息
Smith Jason, Guly Henry
机构信息
Accident and Emergency Department, Derriford Hospital, Plymouth PL6 8DH.
出版信息
BMJ. 2004 Jun 12;328(7453):1426. doi: 10.1136/bmj.328.7453.1426.
Abstract
摘要
相似文献
1
Nalbuphine and slow release morphine.
BMJ. 2004 Jun 12;328(7453):1426. doi: 10.1136/bmj.328.7453.1426.
2
Comparison of intravenous nalbuphine infusion versus saline as an adjuvant for epidural morphine.
Reg Anesth. 1996 May-Jun;21(3):214-8.
3
A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
Pain Med. 2005 Mar-Apr;6(2):113-21. doi: 10.1111/j.1526-4637.2005.05020.x.
4
The absence of 'cross-tolerance' when switching from oral morphine to transdermal fentanyl.
Palliat Med. 1997 Nov;11(6):494-5.
5
Managing chronic cancer pain.
RN. 1998 Nov;61(11):90.
6
Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain.
J Pain Symptom Manage. 2010 Nov;40(5):734-46. doi: 10.1016/j.jpainsymman.2010.05.004.
7
The association of tramadol and morphine in the treatment of acute postoperative pain.
Minerva Anestesiol. 2011 Feb;77(2):239; author reply 240-1. Epub 2011 Feb 1.
8
KADIAN (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain.
Int J Clin Pract. 2008 Mar;62(3):471-9. doi: 10.1111/j.1742-1241.2007.01688.x.
9
Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
J Pharmacol Exp Ther. 1997 Mar;280(3):1159-69.
10
Long-term rectal administration of high-dose sustained-release morphine tablets.
Support Care Cancer. 2002 Nov;10(8):653-5. doi: 10.1007/s00520-002-0357-0. Epub 2002 Apr 25.
引用本文的文献
1
Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review.
Drug Des Devel Ther. 2015 Sep 16;9:5255-67. doi: 10.2147/DDDT.S86983. eCollection 2015.
2
Sedate with caution.
Emerg Med J. 2007 Jan;24(1):69.
本文引用的文献
1
Excessive morphine requirements after pre-hospital nalbuphine analgesia.
J Accid Emerg Med. 1999 Sep;16(5):392. doi: 10.1136/emj.16.5.392.
2
Excessive morphine requirements after pre-hospital nalbuphine analgesia.
J Accid Emerg Med. 1999 Jan;16(1):29-31. doi: 10.1136/emj.16.1.29.
3
Prehospital intravenous nalbuphine administered by paramedics.
Resuscitation. 1994 Mar;27(2):153-8. doi: 10.1016/0300-9572(94)90008-6.
4
The effect of pre-hospital administration of intravenous nalbuphine on on-scene times.
J Accid Emerg Med. 1995 Mar;12(1):20-2. doi: 10.1136/emj.12.1.20.
5
The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects.
Eur J Clin Pharmacol. 1987;33(3):297-301. doi: 10.1007/BF00637566.
6
Nalbuphine analgesia in the prehospital setting.
Am J Emerg Med. 1988 Nov;6(6):634-9. doi: 10.1016/0735-6757(88)90109-x.
7
Antagonist effects of nalbuphine in opioid-dependent human volunteers.
J Pharmacol Exp Ther. 1989 Mar;248(3):929-37.
Zotero 插件